Christopher Mutz
Net worth: 5 M $ as of 2026-05-30
Net worth: 5 M $ as of 2026-05-30
Christopher K.
Mutz is Senior Vice President & Head-Rare Diseases at ANI Pharmaceuticals, Inc. since 2021.
Formerly, Mr. Mutz was National Sales Director-US Metabolic Business Unit at Alexion Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Virginia and an MBA from Johnson Graduate School of Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-15 | 62,245 ( 0.27% ) | 5 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2021-02-16 |
| Companies | Position | End |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions